François Pierre Combes

Exposure–Efficacy Analysis of Asciminib in Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase

François Pierre Combes, Ying Fei Li, Matthias Hoch et al. · Clinical Pharmacology & Therapeutics · 2022 · 34 citations

Medicine, Pharmacokinetics, Pharmacology +13

Physiologically Based Pharmacokinetic Modeling to Supplement Nilotinib Pharmacokinetics and Confirm Dose Selection in Pediatric Patients

Tycho Heimbach, Wen Lin, Florence Hourcade‐Potelleret et al. · Journal of Pharmaceutical Sciences · 2019 · 30 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Prediction of Shrinkage of Individual Parameters Using the Bayesian Information Matrix in Non-Linear Mixed Effect Models with Evaluation in Pharmacokinetics

François Pierre Combes, Sylvie Retout, Nicolas Frey et al. · Pharmaceutical Research · 2013 · 25 citations

Pharmacy, Biostatistics, Pharmacokinetics +12

Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases

Ying Fei Li, François Pierre Combes, Matthias Hoch et al. · Clinical Pharmacokinetics · 2022 · 22 citations

Medicine, Oncology, Pharmacokinetics +14

Model‐Informed Drug Development for Everolimus Dosing Selection in Pediatric Infant Patients

François Pierre Combes, Heidi J. Einolf, Neva Coello et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 17 citations · Full text

Pharmacy, Pediatrics, Pharmacology +14